=== CALIBRATION EXAMPLE 50 ===

# Harsh Critic Review
## Section-by-Section Critical Review

### Title & Abstract
- The title accurately signals the paper’s main idea: a rectified discrete-flow method with annealed updates for multi-objective sequence design. That said, it is quite technical and slightly overstates novelty by implying a clean conceptual unification, whereas the method seems to combine several known ingredients (Tchebycheff scalarization, locally balanced proposals, MH correction) on top of ReDi.
- The abstract clearly states the problem and high-level method, and it identifies peptide/SMILES design as the application domain. However, two claims are stronger than what the paper convincingly substantiates:
  - “theoretical guarantees of convergence to the Pareto front” is stated very broadly, but the formal results in Appendix A appear to apply to an annealed Gibbs distribution over a scalarized objective, not a full algorithmic guarantee that the finite-time procedure reaches or covers the Pareto front.
  - “outperforms both evolutionary and diffusion-based baselines” is plausible from the reported tables, but the comparisons are not strong enough to support the breadth of the claim, especially given the custom benchmarks and some incomplete baseline parity.

### Introduction & Motivation
- The problem is well motivated: biomolecular sequence design is genuinely multi-objective, and discrete sequence spaces are a natural setting for this work. The discussion of the gap between continuous multi-objective generative models and discrete sequence generation is relevant for ICLR.
- The main gap is identified reasonably well: prior discrete flow methods do not directly support Pareto-guided multi-objective sampling. This is a legitimate contribution target.
- The introduction does over-claim in a few places:
  - It says “no framework yet achieves Pareto guidance across multiple objectives” in discrete flows. That may be too absolute given recent guided discrete diffusion / MOO work cited later.
  - The contribution statement “the first multi-objective extension of rectified discrete flows” is probably accurate, but the stronger claim of “convergence to the Pareto front with full coverage” is not established in a practical sense.
- For ICLR standards, the motivation is strong enough, but the framing would benefit from a more careful distinction between theoretical stationary-distribution results and algorithmic Pareto guarantees.

### Method / Approach
- The method is understandable at a high level, but the description is not fully reproducible or logically clean in several key places.
- The core idea is: define a reward-tilted target distribution using Tchebycheff scalarization, construct locally balanced single-coordinate proposals from a ReDi prior, and use MH to preserve the target distribution. This is a reasonable design.
- Major concerns:
  1. **Theoretical target vs. optimization claim.** In Section 3.4 and Appendix A, the stationary distribution is defined as  
     \[
     \pi_{\eta,\omega}(x)\propto p_1(x)\exp(\eta S_\omega(x)).
     \]
     This is a tempered sampling distribution, not a direct Pareto optimizer. The paper repeatedly conflates concentration on maximizers of \(S_\omega\) with convergence to the Pareto front.
  2. **Coverage guarantee is not as strong as stated.** The “Coverage Guarantee” says every Pareto point is visited with positive probability if \(\omega\) is sampled from a full-support distribution and \(\eta\to\infty\). This is a weak asymptotic statement about randomizing over weights, not a finite-sample guarantee of “complete coverage of the Pareto front” as claimed in the abstract and introduction.
  3. **Proof quality is uneven.** The Appendix A proof of invariance is plausible in spirit, but the exposition is not rigorous enough for a theoretical claim that is central to the paper:
     - The acceptance probability is asserted to simplify to 1 with Barker’s function, which is not generally true for MH with Barker-style proposals unless the proposal is constructed in a very specific way.
     - The representability theorem for Pareto points by weighted Tchebycheff scalarization is stated too strongly; in multi-objective optimization this depends on assumptions, and the proof sketch is not sufficient.
     - The proof of unique maximizer appears to rely on perturbation/measure-zero arguments without formalizing them.
  4. **Algorithmic ambiguity.** Algorithm 1 and Section 3 mix time index \(t\), step size \(h\), and iteration count in a way that is not clean. It is also unclear whether the “annealing” parameter is updated per MH step, per sweep, or per full trajectory.
  5. **Monotonicity constraint issue.** In Section 4, the paper says the theoretical guarantees hold only in the infinite-chain limit, so they “introduce a monotonicity constraint” that accepts only token updates increasing the weighted sum. This is a major methodological change, but it seems to alter the chain away from the distribution whose invariance is proved. The paper does not explain the resulting target distribution or whether the reported method still has any of the claimed guarantees.
- Edge cases/failure modes not discussed:
  - What happens when objectives conflict so strongly that the Tchebycheff scalarization induces pathological plateaus?
  - How sensitive is the sampler to the weight vector when the Pareto front is non-convex or disconnected?
  - How does the method behave if the prior \(p_1(x)\) assigns near-zero mass to regions containing Pareto-optimal sequences?

### Experiments & Results
- The experiments are relevant to the claims, but they do not fully validate them at ICLR’s bar for a broad methodological paper.
- Strengths:
  - The paper evaluates on two sequence modalities: wild-type peptide binders and peptide SMILES.
  - It includes ablations for rectification, annealing, weight vectors, and the prior model.
  - It compares against both evolutionary MOO baselines and a diffusion-based baseline (PepTune).
- Major concerns:
  1. **Custom benchmarks and no public dataset.** The paper explicitly says no public benchmark exists and the authors built two benchmarks. That is acceptable, but it increases the burden on the paper to justify benchmark design, dataset splits, and fairness. The manuscript does not sufficiently explain how the target sets were chosen, whether they are representative, and how leakage was prevented between training score models and evaluation targets.
  2. **Evaluation uses surrogate score models heavily.** Most results are based on predicted hemolysis, non-fouling, solubility, half-life, and affinity from learned models. This is fine for a first pass, but the paper presents these scores as if they were ground truth. There is little evidence of calibration, uncertainty, or robustness of these predictors. Because the optimization procedure directly exploits them, reward hacking is a real concern.
  3. **Comparisons are not always apples-to-apples.**  
     - PepTune is adapted to DPLM, but the exact adaptation protocol is not described in enough detail to judge fairness.
     - For wall-clock comparisons, AReUReDi is compared to PepTune under matched time, but only top-2 sequences from much larger PepTune candidate pools are used. The comparison is informative, but it is still asymmetric.
     - Some baselines are only used on some tasks, not all.
  4. **No statistical significance or uncertainty.** Tables report averages over 100 samples, but there are no confidence intervals, standard deviations in the main tables, or significance tests. Given the stochasticity of generative sampling, this is a notable omission.
  5. **Some reported numbers raise plausibility questions.** For instance, many “hemolysis” and “non-fouling” scores are clustered in a narrow band around 0.85–0.94, which makes it hard to judge discriminative power. Also, the strong gains in half-life relative to small changes in other metrics suggest the objective scaling may dominate the trade-off.
  6. **Ablation with monotonicity constraint is problematic.** Table 6 shows a “sampling constraint” dramatically changes performance, but since this constraint is inserted to accelerate convergence, it may be doing much of the optimization work. The main results should clarify whether they reflect AReUReDi proper or AReUReDi plus an extra greedy filter.
  7. **Missing ablations that matter.** The paper would benefit from:
     - a comparison of Tchebycheff scalarization vs. simpler weighted-sum scalarization,
     - an ablation without MH correction,
     - an ablation without the locally balanced proposal but with the same target,
     - and a direct comparison of fixed-η vs. annealed-η across more than two tasks.
- Overall, the experiments show the method can optimize the chosen surrogate objectives, but they do not fully establish the broader claims about Pareto-front coverage or superiority over state of the art in a rigorous ICLR sense.

### Writing & Clarity
- The main narrative is understandable, but several parts are hard to follow in ways that affect the scientific contribution:
  - The distinction between the base ReDi model, PepReDi, PepDFM, and SMILESReDi is not always cleanly maintained.
  - The theoretical section and Algorithm 1 are somewhat difficult to reconcile with the practical use of the monotonicity constraint in Section 4.
  - The relationship between “full coverage of the Pareto front” and randomization over \(\omega\) is not clearly explained.
- Figures and tables are mostly informative, and the captions are helpful. However, some tables are very dense and would benefit from clearer separation of experimental settings from reported metrics.
- The most important clarity issue is conceptual: the paper does not clearly distinguish between:
  1. sampling from a reward-tilted distribution,
  2. asymptotically concentrating on scalarized optima,
  3. and actually approximating the entire Pareto front in finite computation.

### Limitations & Broader Impact
- The paper does acknowledge some limitations in Discussion, notably computational cost and the need for better efficiency and uncertainty-aware guidance.
- However, it misses several key limitations:
  1. **Heavy dependence on surrogate predictors.** Since the method optimizes learned property models, it is vulnerable to model misspecification and adversarial exploitation.
  2. **No wet-lab validation.** All claims are in silico. For therapeutic design, this is a major limitation and should be emphasized more strongly.
  3. **Pareto coverage is not practically guaranteed.** The theoretical results require asymptotic limits and assumptions that do not match the actual constrained sampling procedure used in experiments.
  4. **Safety and dual-use concerns.** The ethics statement is present, but the paper could more concretely discuss misuse risks from generating potent bioactive sequences and the risks of releasing both models and generation code.
- The broader impact statement is reasonable but somewhat generic for a biomolecular design paper. ICLR expects honest discussion of where methods might fail or be misused; this paper could do more there.

### Overall Assessment
AReUReDi is a plausible and interesting combination of discrete flow modeling, Tchebycheff scalarization, and MH-based guidance for multi-objective biological sequence design, and the experimental results suggest it can improve surrogate objective trade-offs on the chosen benchmarks. However, the paper currently overstates its theoretical guarantees and, to some extent, its empirical conclusiveness. The biggest issue is the mismatch between the claimed “convergence to the Pareto front with full coverage” and what is actually proved and implemented, especially given the added monotonicity constraint. At ICLR, this would likely be viewed as a promising but not yet fully convincing method paper: the contribution stands, but the central claims need to be narrowed and supported more rigorously before it meets the stronger acceptance bar.

# Neutral Reviewer
## Balanced Review

### Summary
This paper proposes AReUReDi, a multi-objective discrete sequence optimization framework built on rectified discrete flows (ReDi), annealed Tchebycheff scalarization, locally balanced proposals, and Metropolis–Hastings updates. The authors claim theoretical guarantees of invariance, Pareto-front convergence, and Pareto coverage, and demonstrate the method on peptide and peptide-SMILES generation tasks with up to five objectives.

### Strengths
1. **Timely problem setting with clear practical relevance.**  
   Multi-objective biological sequence design is an important and underexplored problem, and the paper targets several realistic objectives (affinity, solubility, hemolysis, half-life, non-fouling) that are indeed relevant for therapeutic design.

2. **A principled attempt to combine discrete generative modeling with multi-objective optimization.**  
   The method is not just heuristic search: it builds on a learned discrete flow prior and combines it with Tchebycheff scalarization and MCMC-style updates. This is conceptually appealing because it aims to preserve the structure of the sequence generator while steering samples toward desirable trade-offs.

3. **Ablation studies support some design choices.**  
   The paper includes ablations for rectification, annealed guidance strength, the sampling constraint, and weight-vector effects. These experiments suggest that the proposed ingredients are intended to matter individually, not only in combination.

4. **Broad experimental coverage across multiple sequence domains.**  
   The paper evaluates on wild-type peptide binders and chemically modified peptide SMILES, suggesting the framework is intended to generalize beyond a single benchmark or representation.

5. **The paper provides substantial implementation detail.**  
   The appendix includes model architectures, training settings, scoring-model details, and sampling configurations, which is helpful for understanding the overall pipeline.

### Weaknesses
1. **The theoretical guarantees appear substantially overstated relative to the actual algorithm.**  
   The paper claims “convergence to the Pareto front” and “full coverage,” but the proof relies on a fixed scalarization and asymptotic concentration as \(\eta \to \infty\). This does not, by itself, guarantee that the algorithm will find all Pareto-optimal solutions in finite time, nor that the practical annealed sampler covers the Pareto front. In particular, the “coverage guarantee” is only shown through randomizing weights with full support, while actual experiments use fixed weights in most settings.

2. **The methodology is not fully aligned with its own theoretical story.**  
   The paper states that Metropolis–Hastings enables exact invariance, yet also introduces a “monotonicity constraint” that accepts only updates increasing the weighted sum. This additional constraint changes the Markov chain and appears to violate the exact sampling/invariance claims unless carefully incorporated into the target kernel, which is not shown.

3. **Experimental evaluation lacks convincing external validation.**  
   The scores are entirely model-predicted, and the paper does not present wet-lab validation or even strong external robustness checks. Because the objective models are themselves learned predictors, the reported gains may reflect exploitation of surrogate-model biases rather than genuine improvements in biological properties.

4. **The benchmark setup is somewhat self-referential and may favor the proposed pipeline.**  
   AReUReDi is evaluated using base generators and scoring models that are developed in-house or adapted from closely related work, with limited evidence that the comparison is fair under matched model capacity, compute, and oracle quality. For example, the paper compares against evolutionary methods and PepTune, but some comparisons are complicated by differing candidate budgets and wall-clock settings.

5. **The results are difficult to interpret quantitatively as evidence of Pareto optimality.**  
   The paper mainly reports average scores over generated samples rather than standard multi-objective metrics such as hypervolume, epsilon indicator, or Pareto front quality/coverage statistics. Without such metrics, it is hard to judge whether the method truly improves the Pareto frontier rather than simply shifting averages.

6. **Reproducibility is only partial at this stage.**  
   Although many hyperparameters are described, key elements remain underspecified for exact reproduction, including the precise objective normalization procedure, the implementation of the “locally balanced proposals” under candidate pruning, the exact evaluation pipelines for scoring models, and the details of the hidden data curation and filtering steps for the benchmarks.

7. **There are signs of overclaiming in the experimental narrative.**  
   Statements such as “outperforms both evolutionary and diffusion-based baselines” and “complete coverage of the Pareto front” are too strong given the surrogate-based evaluation, limited benchmark diversity, and the absence of standard Pareto metrics and ground-truth validation.

### Novelty & Significance
**Novelty: Moderate.** The combination of rectified discrete flows, Tchebycheff scalarization, and MCMC-guided updates is a reasonable synthesis, but each component is drawn from established lines of work. The main novelty is the adaptation of these ideas to discrete biomolecular sequence generation and the attempt to frame the method with Pareto-oriented guarantees.

**Clarity: Moderate.** The high-level idea is understandable, but the presentation of the theoretical claims and the exact algorithmic details is not sufficiently crisp. In particular, the interaction between annealing, local proposals, and MH acceptance is hard to reconcile with the stronger claims made in the abstract.

**Reproducibility: Moderate to Low.** The paper includes many implementation details, but important parts of the pipeline are still underspecified, and the experiments rely heavily on internal predictive models. The lack of released code/checkpoints at submission time also limits reproducibility.

**Significance: Moderate.** If validated more rigorously, this could be a useful framework for discrete multi-objective generation in biology. However, at the current stage the evidence is not strong enough for a high-impact ICLR acceptance without a more careful theoretical framing and stronger empirical validation.

Overall, for ICLR standards, this is an interesting and potentially useful paper, but it currently falls short of the bar for a strong acceptance because the theoretical claims are too ambitious for the proofs provided and the experimental validation is not sufficiently robust.

### Suggestions for Improvement
1. **Tone down and sharpen the theoretical claims.**  
   Replace absolute statements like “guarantees convergence to the Pareto front with full coverage” with precise asymptotic or conditional statements. Explicitly distinguish what is proven for the idealized target distribution from what is actually achieved by the finite-step annealed algorithm.

2. **Integrate the monotonicity constraint into the theory or remove it from the main method.**  
   If this constraint is essential in practice, the paper should analyze its effect on invariance and convergence. Otherwise, it should be presented as a heuristic ablation rather than part of the core method.

3. **Report standard multi-objective metrics.**  
   Add hypervolume, dominated set size, epsilon-indicator, and Pareto coverage metrics, ideally with confidence intervals across multiple random seeds. This would make the claims about Pareto-front quality much more convincing.

4. **Include stronger baselines and matched-budget comparisons.**  
   Compare against additional discrete guidance methods, preferably under matched compute and matched oracle calls. If some baselines cannot be directly compared, explain why and report a careful budget-matched protocol.

5. **Validate against more trustworthy evaluation signals.**  
   Add sensitivity analyses for the scoring models, calibration checks, and if possible a small wet-lab or external dataset validation. At minimum, test whether improvements persist under alternative surrogate models.

6. **Clarify the exact implementation of local balancing and candidate pruning.**  
   The paper should specify how top-p candidate pruning interacts with proposal symmetry and MH correction, and whether the theoretical invariance still holds under restricted candidate sets.

7. **Improve the presentation of the Pareto-weight exploration.**  
   Show how varying \(\omega\) traces different regions of the frontier using Pareto plots, not just scalar average scores. A 2D/3D frontier visualization and coverage analysis would make the method’s behavior easier to assess.

8. **Provide a more explicit reproducibility package.**  
   Release code, checkpoints, scoring models, exact preprocessing scripts, and the exact benchmark splits. Given the dependence on learned property predictors, this is especially important for verification by the community.

# Spark Finder Review
## How to Improve This Paper

### Missing Experiments (top 3-5 only)
1. Add a proper comparison to the strongest *discrete* multi-objective baselines on the same sequence domain, not just general MOO heuristics. For ICLR, the core claim is a new generative method; without head-to-head results versus guided discrete diffusion/flow methods with matched budgets and identical score models, the claimed SOTA over multi-objective sequence generation is not convincing.

2. Add oracle-based or experimentally validated evaluation for a small subset of designs. All main claims rest on predicted hemolysis/solubility/half-life/affinity scores; without wet-lab validation or at least independent oracle checks from held-out/alternative predictors, the paper only shows that it can exploit its own scoring models.

3. Add an end-to-end comparison under equal compute and equal candidate budget against PepTune and ReDi-based alternatives. The paper repeatedly uses much larger sampling budgets and then compares outputs; ICLR reviewers will expect matched wall-clock, matched number of score queries, and best-of-\(N\) comparisons to rule out a pure compute advantage.

4. Add a baseline that uses the same base generator and the same scalarized MH search, but without rectification or without locally balanced proposals. Right now the method claim is a combination of ReDi + annealing + MCMC; the paper does not isolate which component actually drives the improvement in Pareto trade-offs.

5. Add sensitivity experiments over the number of objectives and weight distributions. The paper claims up to five-objective Pareto optimization, but only a few fixed weight settings are shown; without systematic sweeps over weights, objective count, and initialization, it is unclear whether the method really scales or just works on hand-picked cases.

### Deeper Analysis Needed (top 3-5 only)
1. Add empirical convergence analysis of the Markov chain, not just asymptotic theory. The paper claims convergence to the Pareto front, but the experiments also admit that guarantees hold only in the infinite-chain limit; reviewers need diagnostics showing mixing, acceptance rates, and whether practical runs are anywhere near stationarity.

2. Add calibration/error analysis of the surrogate objective models. Since the optimization is entirely driven by learned predictors, the paper needs uncertainty or reliability analysis on the score models, especially for extrapolative sequences, because adversarial exploitation could fully explain the reported gains.

3. Add a Pareto-front quality analysis using hypervolume, coverage, and dominance counts on the *same* set of generated candidates. Current tables report per-objective averages, which can hide trade-offs and do not establish that the method actually approximates the Pareto frontier rather than averaging over mediocre samples.

4. Add an analysis of the role of rectification versus the quality of the learned prior. The paper claims rectification improves factorization error and downstream optimization, but it never shows whether the gain comes from a better prior distribution, better score guidance, or simply more training and sampling compute.

5. Add an explicit failure-mode analysis for invalid, repetitive, or chemically implausible outputs. The method claims “full coverage” and biologically plausible designs, but the paper does not characterize when proposals collapse, produce invalid sequences, or exploit loopholes in the SMILES/peptide validity filters.

### Visualizations & Case Studies
1. Add true Pareto scatter plots for each task, showing all generated samples in objective space against baselines. This would expose whether AReUReDi actually spans the frontier or just shifts the mean of a few objectives while sacrificing others.

2. Add trajectory plots for individual chains: objective scores, acceptance rates, and state changes over iterations. This would reveal whether annealing produces meaningful exploration-to-exploitation behavior or whether the chain quickly freezes or cycles.

3. Add nearest-neighbor and edit-distance case studies for top designs. This is needed to show whether the method generates genuinely novel sequences or merely memorizes training motifs while optimizing the surrogate scores.

4. Add qualitative examples of failure cases where one objective improves but another collapses. Since the paper’s central claim is multi-objective balancing, the most informative visualization is a set of side-by-side successes/failures under different weight vectors and step budgets.

5. Add uncertainty-aware score heatmaps for representative designed sequences. This would show whether the reported high-scoring candidates are robust or depend on uncertain extrapolations from the scoring models.

### Obvious Next Steps
1. Validate a small number of designed peptides in vitro or against external binding/solubility/aggregation assays. For an ICLR paper making strong biomolecular design claims, this is the clearest way to make the contribution believable.

2. Extend the method to a genuinely harder benchmark with shared public evaluation protocol. The current benchmarks are custom-built and heavily dependent on internal scorers; the obvious next step is a community benchmark with fixed targets, fixed scoring oracles, and standardized Pareto metrics.

3. Release a complete reproducible pipeline with exact scoring models, target-specific preprocessing, and all hyperparameters. Given how much the results depend on internal predictors and custom sampling constraints, this is necessary for others to verify the claimed gains.

4. Add a principled multi-objective stopping rule instead of fixed iteration counts. The paper’s current practical success depends on large step budgets; an obvious next step is an adaptive criterion based on Pareto improvement or chain diagnostics.

5. Generalize to other discrete biological modalities only after demonstrating robustness on the current tasks. The method is presented as broadly applicable, but the current evidence is narrow and peptide-centric; the paper should first establish reliability before claiming transfer to DNA, RNA, antibodies, or genotype libraries.

# Final Consolidated Review
## Summary
This paper proposes AReUReDi, a multi-objective extension of rectified discrete flows for biological sequence design. The method combines a ReDi prior, annealed Tchebycheff scalarization, locally balanced proposals, and Metropolis-Hastings updates to steer discrete sampling toward Pareto-optimal sequences, with experiments on peptide binders and peptide-SMILES generation.

## Strengths
- The paper tackles a genuinely relevant problem: multi-objective optimization in discrete biological sequence spaces, where trade-offs such as affinity, solubility, hemolysis, and half-life matter in practice.
- The method is conceptually coherent as a synthesis of a learned discrete prior with explicit multi-objective guidance, and the appendix provides substantial implementation detail for the base generators, scoring models, and sampling setup.
- The ablation suite does support some of the intended design choices, especially the effects of rectification, annealed guidance, and the learned prior versus a uniform prior.

## Weaknesses
- The theoretical claims are overstated relative to what is actually proved. The paper repeatedly claims convergence to the Pareto front with full coverage, but the formal results are asymptotic statements about a reward-tilted distribution under idealized assumptions, not a practical guarantee that the finite-step algorithm recovers or covers the Pareto front. This is a central mismatch.
- The practical method departs from the claimed theory in a nontrivial way: the experiments introduce a monotonicity constraint that accepts only improvements in weighted sum. This changes the Markov chain and is not reconciled with the invariance/convergence analysis, so the main algorithm is not the one actually analyzed.
- The empirical evidence is not yet strong enough for the strength of the claims. Most results rely on surrogate predictors rather than ground-truth or experimental validation, and the paper does not report standard Pareto-quality metrics such as hypervolume or coverage. As a result, it is hard to tell whether AReUReDi truly approximates a Pareto front or merely improves average surrogate scores.
- Comparisons are only partially convincing. Some baselines are adapted in ways that are not fully specified, budgets are asymmetric in several places, and there is no confidence interval or significance analysis. Given the stochastic nature of generation and the reliance on learned score models, this weakens the credibility of the reported gains.

## Nice-to-Haves
- Report standard multi-objective metrics such as hypervolume, epsilon indicator, and Pareto coverage, with multiple seeds and uncertainty estimates.
- Add explicit mixing/trajectory diagnostics for the Markov chain, including acceptance rates and convergence behavior under the annealing schedule.
- Clarify the role of the monotonicity constraint, or move it out of the main method and treat it as a heuristic post-processing choice.

## Novel Insights
The most interesting aspect of the paper is not any one component in isolation, but the attempt to make discrete flow models behave like a principled Pareto sampler rather than a heuristic generator. In particular, the paper’s use of Tchebycheff scalarization plus locally balanced MH proposals is a plausible way to keep the generator anchored in a learned discrete prior while biasing it toward trade-off regions; that is a genuinely appealing direction. However, the current implementation blurs the line between exact sampling theory and greedy optimization, which undercuts the conceptual cleanliness of the approach.

## Potentially Missed Related Work
- ParetoFlow — relevant as a continuous-space multi-objective generative baseline and for comparison of Pareto-guided flow ideas.
- Proud / guidance-based discrete diffusion for multi-objective generation — relevant because the paper positions itself against multi-objective discrete generative methods and should compare more directly to the strongest guided discrete alternatives.
- Multi-objective GFlowNets — relevant as another principled generative framework for exploring Pareto trade-offs in combinatorial spaces.

## Suggestions
- Tighten the main claims to match the actual theorem statements: distinguish invariance of a tilted distribution from Pareto-front coverage in finite computation.
- Either analyze the monotonicity constraint formally or remove it from the core algorithm description.
- Add Pareto-front visualizations and hypervolume-based evaluation on the exact same candidate sets used in the tables.
- Include stronger budget-matched comparisons to discrete guided generation baselines with identical score models and compute budgets.
- Provide robustness checks for the surrogate objective models, since the entire optimization pipeline is vulnerable to reward hacking.

# Actual Human Scores
Individual reviewer scores: [4.0, 6.0, 2.0, 4.0]
Average score: 4.0
Binary outcome: Reject
